Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis

Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis

<b>Background</b>: Hepatocellular carcinoma (HCC) is a prevalent liver cancer with poor prognosis, often linked to hepatitis B (HBV) and C (HCV) infections. This meta-analysis evaluates the efficacy of immunotherapy in HCC, particularly in cases arising from viral hepatitis. <b>Met...

Full description

Saved in:

Bibliographic Details
Main Authors:	Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, Juwairiya Shuroog, Ahmed Abdelhakeem, Ali Saeed, Anwaar Saeed
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Current Oncology
Subjects:	hepatocellular carcinoma immunotherapy hepatitis B hepatitis C objective response survival
Online Access:	https://www.mdpi.com/1718-7729/31/11/532
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
by: Chiao-Ling Li, et al.
Published: (2025-01-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes
by: Chuankuo Zhang, et al.
Published: (2025-01-01)

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
by: Zizhuo Wang, et al.
Published: (2025-01-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis
by: Abdullah A. Awadh, et al.
Published: (2024-12-01)

Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
by: Young Mi Hong
Published: (2024-12-01)

Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma
by: Xinyue Liu, et al.
Published: (2024-12-01)

Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting
by: Xueshuai Wan, et al.
Published: (2024-10-01)

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
by: Yimin Zheng, et al.
Published: (2023-10-01)

Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B
by: Gi-Ae Kim, et al.
Published: (2024-10-01)

PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
by: He Z, et al.
Published: (2025-01-01)

Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
by: Yannan Qiao, et al.
Published: (2024-12-01)

Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy
by: Haochen Yao, et al.
Published: (2024-11-01)

Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
by: Paul Y. Kwo
Published: (2024-10-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-directacting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
by: Seren M. Gedallovich, et al.
Published: (2024-10-01)

Primary hepatic carcinosarcoma combined with hepatocellular carcinoma: A case report
by: Ziyi Wang, et al.
Published: (2025-01-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation
by: Wu KC, et al.
Published: (2024-11-01)

Hepatic and perihepatic PEComas: A study describing a series of five rare cases
by: P Vijayanirmala, et al.
Published: (2024-04-01)

Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
by: Beom Kyung Kim
Published: (2024-10-01)

Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination
by: Angela Domínguez, et al.
Published: (2024-11-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
by: Yaqin Zhang, et al.
Published: (2024-12-01)

The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients
by: Zhengzheng Ji, et al.
Published: (2024-11-01)

Comparison of the performances between ChatGPT and Gemini in answering questions on viral hepatitis
by: Meryem Sahin Ozdemir, et al.
Published: (2025-01-01)

Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection
by: Henry L. Y. Chan, et al.
Published: (2024-11-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
by: Karina Gonzalez-Aldaco, et al.
Published: (2024-11-01)

MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX
by: Amrizal Muchtar, et al.
Published: (2025-01-01)

Cancer Cell‐Derived Exosomal miR‐500a‐3p Modulates Hepatic Stellate Cell Activation and the Immunosuppressive Microenvironment
by: Yu Zhang, et al.
Published: (2025-01-01)

KIF20A activated by transcription factor GATA2 promotes cell growth in hepatitis B virus-related hepatocellular carcinoma
by: Juan Xu, et al.
Published: (2024-11-01)

Probability analysis of hepatocellular carcinoma in hepatitis patients in the gray zone
by: Jianna Zhang, et al.
Published: (2024-12-01)

Study of Hematological Changes In Acute Viral Hepatitis In Children in MUCH
by: rasha elashery, et al.
Published: (2014-08-01)

Factors associated with seropositivity of Hepatitis B & C: A case control study at Azad Jammu and Kashmir
by: Muhammad Abdul Quddus, et al.
Published: (2023-04-01)

Long-term Outcomes (10 years) of Hepatic Transplantation in a Patient with Hepatic Adenomatosis: A Case Report
by: Abdullah Almunifi
Published: (2024-12-01)

Global progress, challenges and strategies in eliminating public threat of viral hepatitis
by: Sihui Zhang, et al.
Published: (2025-02-01)

Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis
by: Ting Sun, et al.
Published: (2024-08-01)

Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
by: Ji Yeon Lee, et al.
Published: (2024-12-01)